Utility of the CAT in the therapy assessment of COPD exacerbations in China

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Tu, You Hui ^a   Zhang, Yan ^a   Fei, Guang He ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease assessment test; Exacerbation; Inflammatory biomarkers; Pulmonary function; Therapy assessment

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

AGED; ARTICLE; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSESSMENT TEST; DISEASE EXACERBATION; DYSPNEA; FEMALE; FIBRINOGEN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITAL PATIENT; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MODIFIED MEDICAL RESEARCH COUNCIL SCALE; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT RESPONSE; CLINICAL ASSESSMENT TOOL; COPD ASSESSMENT TEST; INFLAMMATION; LUNG FUNCTION; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE;

AGED; CHINA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 84899151325     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-42     Document Type: Article

References (34)

1. Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest 2011, 139(4):920-929. 10.1378/chest.10-1393, 21467059.
2. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez- Roisin R. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187(4):347-365. 10.1164/rccm.201204-0596PP, 22878278.
3. Wedzicha JA, Donaldson GC. Natural history of successive COPD exacerbations. Thorax 2012, 67(11):935-936. 10.1136/thoraxjnl-2012-202087, 22858927.
4. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422. 10.1164/ajrccm.157.5.9709032, 9603117.
5. Gross NJ. Outcome measures for COPD treatments: a critical evaluation. COPD 2004, 1(1):41-57. 10.1081/COPD-120030413, 16997738.
6. Jones PW, Harding G, Wiklund I. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009, 18:208-215. 10.4104/pcrj.2009.00053, 19690787.
7. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy NK. Development and first validation of the COPD assessment test. Eur Respir J 2009, 34(3):648-654. 10.1183/09031936.00102509, 19720809.
8. CAT development steering group: COPD assessment test-healthcare professional user guide. http://www.catestonline.org.
9. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluña JJ, van der Molen T, Adamek L, Banik N. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011, 38:29-35. 10.1183/09031936.00177210, 21565915.
10. Marchand E, Maury G. Evaluation of the COPD assessment test in patients with stable COPD. Rev Mal Respir 2012, 29(3):391-397. 10.1016/j.rmr.2011.09.043, 22440303.
11. Kelly JL, Bamsey O, Smith C, Lord VM, Shrikrishna D, Jones PW, Polkey MI, Hopkinson NS. Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration 2012, 84(3):193-199. 10.1159/000336549, 22441322.
12. Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, Leidy NK. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest 2012, 142(1):134-140.
13. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012, 185(11):1218-1224. 10.1164/rccm.201110-1843OC, 22281834.
14. Wiklund I, Berry P, Lu KX. The Chinese translation of COPD assessment test (CAT) provides a valid and reliable measurement of COPD health status in Chinese COPD patients. Am J Respir Crit Care Med 2010, 181:A3575.
15. Perera WR, Hurst JR, Wilkinson TMA, Sapsford RJ, Mullerova H, Donaldson GC, Wedzicha JA. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007, 29(3):527-534. 10.1183/09031936.00092506, 17107990.
16. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, Jeffries DJ, Meade TW. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000, 84(2):210-215.
17. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003, 48(12):1204-1213.
18. Quint JK, Donaldson GC, Hurst JR, Goldring JJ, Seemungal TR, Wedzicha JA. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J 2011, 37:501-507. 10.1183/09031936.00035909, 20650988.
19. van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008, 75:224-238. 10.1159/000111820, 18042978.
20. Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tanuleria E, Sánchez G, Sobradillo V, Ancochea J. Systemic inflammation in chronic obstructive pulmonarydisease: a population-based study. Respir Res 2010, 11(1):63. 10.1186/1465-9921-11-63, 2891677, 20500811.
21. Doyle TJ, Pinto-Plata V, Morse D, Celli BR, Rosas IO. The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases. Chest 2012, 142:1027-1034. 10.1378/chest.1462799, 3465104, 23032451.
22. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Biello JA, Hagan GW, Vessey RS, Wedzicha JA. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174(8):867-874. 10.1164/rccm.200604-506OC, 16799074.
23. Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R, Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 2011, 12:146. 10.1186/1465-9921-12-146, 3247194, 22054035, Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators.
24. Murphy TF. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 2006, 19:225-230. 10.1097/01.qco.0000224815.89363.15, 16645482.
25. Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004, 1:115-120. 10.1513/pats.2306030, 16113423.
26. Snoeck-Stroband JB, Postma DS, Lapperre TS, Gosman MM, Thiadens HA, Kauffman HF, Sont JK, Jansen DF, Srerk PJ. Airway inflammation contributes to health status in COPD: a cross-sectional study. Respir Res 2006, 7(1):140. 10.1186/1465-9921-7-140, 1697818, 17137518.
27. Mohan A, Prasad D, Sharma A, Arora S, Guleria R, Sharma SK, Pandey RM. Delayed resolution of inflammatory response compared with clinical recovery in patients with acute exacerbations of chronic obstructive pulmonary disease. Respirology 2012, 17(7):1080-1085. 10.1111/j.1440-1843.2012.02216.x, 22758397.
28. Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, Siafakas N, Tzanakis N. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012, 12:20. 10.1186/1471-2466-12-20, 3431277, 22607459.
29. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, Falzon C, Garrod R, Lee C, Polkey MI, Jones PW, Man WDC, Hopkinson NS. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011, 66(5):425-429. 10.1136/thx.2010.156372, 21398686.
30. Dodd JW, Marns PL, Clark AL, Ingram KA, Fowler RP, Canavan JL, Patel MS, Kon SS, Hopkinson NS, Polkey MI, Jones PW, Man WD. The COPD assessment test (CAT): short and medium-term response to pulmonary rehabilitation. COPD 2012, 9(4):390-394.
31. Zhou QT, Mei JJ, He B, Huang SG, Wen FQ, Zhao MW. Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients. Chin Med J (Eng) 2013, 126(1):11-15.
32. Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J 2013, 42(3):647-654. 10.1183/09031936.00125612, 23258783.
33. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161(5):1608-1613. 10.1164/ajrccm.161.5.9908022, 10806163.
34. Halpin DM, Decramer M, Celli B, Kesten S, Dacheng L, Tashkin DP. Exacerbation frequency and course of COPD. Int J Chro Obstruct Pulmon Dis 2012, 7:6.